Important Notice
This is accepted manuscript by the journal but prior to copy-editing or proofing. It can be cited using the author(s), article title, journal title, year of online publication, and DOI. It will be replaced by the final typeset version, which may therefore contain changes. The DOI will be remain the same.
Systemic review of Macleaya cordata: genetics, biosynthesis of active ingredient and functions
-
Peng Huang1,2,3,
-
Pi Cheng1,2,3,
-
Mengshan Sun2,4,
-
Xiubin Liu1,2,3,
-
Zhixing Qing1,2,3,
-
YiSong Liu1,2,3,
-
Zihui Yang1,2,3,
-
Hua Liu5,
-
Changhong Li5 &
-
Jianguo Zeng1,2,3,6, ,
-
1.
Hunan Key Laboratory of Traditional Chinese Veterinary Medicine, Hunan Agricultural University, Changsha 410128, Hunan, China
-
2.
Traditional Chinese Medicine Breeding Center of Yuelushan Laboratory, Changsha 410128, Hunan, China
-
3.
College of Veterinary Medicine, Hunan Agricultural University, Changsha 410128, Hunan, China
-
4.
Hunan Institute of Agricultural Environment and Ecology, Hunan Academy of Agricultural Sciences, Changsha 410125, Hunan, China
-
5.
Micolta Bioresource Inc., Changsha 410016, Hunan, China
-
6.
National and Local Union Engineering Research Center of Veterinary Herbal Medicine Resource and Initiative, Hunan Agricultural University, Changsha 410128, Hunan, China
More Information
-
Received:
20 May 2024
Revised:
19 July 2024
Accepted:
26 July 2024
First-online:
07 August 2024
Medicinal Plant Biology
Article in press
|
Cite this article
-
Abstract
Macleaya cordata, a medicinal plant in the Papaveraceae family, is rich in bioactive benzylisoquinoline alkaloids. Recent research has elucidated the mechanisms by which these active components promote livestock and poultry growth and exhibit anti-inflammatory effects on the intestines. These findings have led to the development of two raw medicinal materials and two veterinary drug formulations, widely used in China's livestock industry. Advances in multi-omics technologies, such as whole-genome sequencing and transcriptomics, have clarified the chemical composition of alkaloids and the biosynthesis of sanguinarine, enabling its de novo synthesis in yeast. Efforts in plant breeding have focused on cultivar selection and germplasm innovation, establishing DUS (Distinctness, Uniformity, and Stability) testing guidelines. Genetic engineering techniques have re-edited the sanguinarine pathway and induced hairy roots and cell suspension cultures in M. cordata. These advancements reduce production costs, ensure product stability, and promote sustainable production. This paper reviews the species origin, current research status, and future prospects of M. cordata, offering guidance for further research on this valuable resource.
-
Rights and permissions
Copyright: © 2024 by the author(s). Published by Maximum Academic Press, Fayetteville, GA. This article is an open access article distributed under Creative Commons Attribution License (CC BY 4.0), visit https://creativecommons.org/licenses/by/4.0/.
-
About this article
Cite this article
Huang P, Cheng P, Sun M, Liu X, Qing Z, et al. 2024. Systemic review of Macleaya cordata: genetics, biosynthesis of active ingredient and functions. Medicinal Plant Biology doi: 10.48130/mpb-0024-0019
Huang P, Cheng P, Sun M, Liu X, Qing Z, et al. 2024. Systemic review of Macleaya cordata: genetics, biosynthesis of active ingredient and functions. Medicinal Plant Biology doi: 10.48130/mpb-0024-0019
|